CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 0 Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Alzheimer's Disease and Other Tauopathies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02531360
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:21.254189+00:00
- Published At
- 2016-12-16T00:00:00+00:00
- Record Updated At
- 2016-12-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Alzheimer\u0027s Disease (AD)", "Progressive Supranuclear Palsy (PSP)", "Cortical Basal Syndrome (CBS)", "Frontal Temporal Dementia (FTD)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-12-16"- protocolSection.identificationModule.nctId
"NCT02531360"- protocolSection.identificationModule.officialTitle
"Phase 0 Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Alzheimer\u0027s Disease and Other Tauopathies"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.